000 01478 a2200457 4500
005 20250516034035.0
264 0 _c20120103
008 201201s 0 0 eng d
022 _a1545-5017
024 7 _a10.1002/pbc.23149
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSalim, Adeline
245 0 0 _aNeuroblastoma: a 20-year experience in a UK regional centre.
_h[electronic resource]
260 _bPediatric blood & cancer
_cDec 2011
300 _a1254-60 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCancer Care Facilities
_xstatistics & numerical data
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aChild, Preschool
650 0 4 _aCombined Modality Therapy
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aMale
650 0 4 _aNeoplasm Staging
650 0 4 _aNeuroblastoma
_xmortality
650 0 4 _aNeurosurgical Procedures
_xmethods
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
650 0 4 _aUnited Kingdom
700 1 _aMullassery, Dhanya
700 1 _aPizer, Barry
700 1 _aMcDowell, Heather P
700 1 _aLosty, Paul D
773 0 _tPediatric blood & cancer
_gvol. 57
_gno. 7
_gp. 1254-60
856 4 0 _uhttps://doi.org/10.1002/pbc.23149
_zAvailable from publisher's website
999 _c20788639
_d20788639